The Relay 250-mm thoracic stent-graft is commercially available in Europe in both straight and taper configurations.
The company received CE approval for Relay in April 2005 for thoracic aortic pathologies including aneurysms, dissections, penetrating ulcers and intramural hematomas. To date, approximately 250 patients have been successfully treated worldwide.
